Search | Clinical Trials Finder

These results were retrieved from the live ClinicalTrials.gov registry. Filters and sort order apply to this result list.

ClinicalTrials.gov public records Last synced Nov 7, 2026, 8:24 AM EST

All trial information on this site comes from the official ClinicalTrials.gov public API (clinicaltrials.gov/api/v2), run by the U.S. National Library of Medicine. We only display that public information; we do not add opinions, endorsements, or any other intent. Always review the official ClinicalTrials.gov record for the latest information.

Showing 1177–1200 of 8,689 matching trials from the live ClinicalTrials.gov search.

Filters: Condition: Longitudinal Studies Clear all

Conditions: Type1diabetes
Interventions: SteadiSet Extended Wear Infusion Set; Device
Lead sponsor: Tandem Diabetes Care, Inc.; Industry
Eligibility: 18 Years to 80 Years
Enrollment: 260 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2024
U.S. locations: 15
States / cities: Newport Beach, California • Stanford, California • Aurora, Colorado + 12 more

Conditions: Peripheral Vascular Disease, Hemorrhage
Interventions: EVICEL ™ Fibrin Sealant (Human); Biological
Lead sponsor: Ethicon, Inc.; Industry
Eligibility: 18 Years and older
Enrollment: 300 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2010 – 2014
U.S. locations: 2
States / cities: Jacksonville, Florida

Conditions: STEMI
Interventions: Impella unloading prior to PPCI; Device
Lead sponsor: Abiomed Inc.; Industry
Eligibility: 21 Years to 80 Years
Enrollment: 50 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2017 – 2018
U.S. locations: 15
States / cities: Phoenix, Arizona • Marietta, Georgia • Detroit, Illinois + 12 more

Conditions: Heart Failure
Interventions: Rheos® system; Device
Lead sponsor: CVRx, Inc.; Industry
Eligibility: 21 Years and older
Enrollment: 19 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2009 – 2021
U.S. locations: 22
States / cities: Mobile, Alabama • Inglewood, California • Los Angeles, California + 18 more

Conditions: Covid19, Outcome, Fatal, Respiratory Failure, Acute Kidney Injury, Inflammation
Interventions: SuPAR, C-reactive protein, Ferritin, D-Dimer, Procalcitonin, Interleukin-6, Lactate Dehydrogenase; Diagnostic Test
Lead sponsor: University of Michigan; Other
Eligibility: 18 Years and older
Enrollment: 4,463 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2020 – 2022
U.S. locations: 1
States / cities: Ann Arbor, Michigan

Conditions: Germ Cell Tumor, Metachronous Malignant Neoplasm, Seminoma, Stage I Testicular Cancer AJCC v8, Stage IA Testicular Cancer AJCC v8, Stage IB Testicular Cancer AJCC v8, Stage IS Testicular Cancer AJCC v8
Interventions: Biomarker Analysis, Blood Product Collection; Other · Procedure
Lead sponsor: SWOG Cancer Research Network; Network
Eligibility: 18 Years and older
Enrollment: 956 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2020 – 2028
U.S. locations: 412
States / cities: Gilbert, Arizona • Kingman, Arizona • Tucson, Arizona + 261 more

Conditions: Patellofemoral Pain Syndrome
Interventions: Algorithm based Exercise Videos, PDF Exercise Sheets, Limited Exercise Videos; Other
Lead sponsor: Simpletherapy; Industry
Eligibility: 18 Years to 64 Years
Enrollment: 85 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2012 – 2013
U.S. locations: 1
States / cities: Philadelphia, Pennsylvania

Conditions: Indication for Care or Intervention Related to Labor or Delivery With Baby Delivered
Interventions: Not listed
Lead sponsor: Brigham and Women's Hospital; Other
Eligibility: Female only
Enrollment: 400 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2014 – 2027
U.S. locations: 1
States / cities: Boston, Massachusetts

Conditions: Antibiotic Prophylaxis Surgery
Interventions: CeFAZolin 1000 MG, Saline (0.9%, sterile, for infusion); Drug
Lead sponsor: Rutgers, The State University of New Jersey; Other
Eligibility: 18 Years and older
Enrollment: 25 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2025 – 2026
U.S. locations: 1
States / cities: Somerset, New Jersey

Conditions: Fibroid Uterus
Interventions: Bupivacaine, Bupivacaine liposome, normal saline; Drug
Lead sponsor: Icahn School of Medicine at Mount Sinai; Other
Eligibility: 18 Years to 64 Years · Female only
Enrollment: 140 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2020 – 2025
U.S. locations: 1
States / cities: New York, New York

Conditions: Degenerative Disc Disease, Spine Degeneration
Interventions: Autologous Bone Marrow Aspirate Concentrate (BMAC) Injection; Other
Lead sponsor: Bone and Joint Clinic of Baton Rouge; Other
Eligibility: 18 Years to 60 Years
Enrollment: 20 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2019 – 2022
U.S. locations: 1
States / cities: Baton Rouge, Louisiana

Conditions: Upper Extremity Pain
Interventions: Senza; Device
Lead sponsor: Nevro Corp; Industry
Eligibility: 18 Years and older
Enrollment: 64 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2016 – 2018
U.S. locations: 1
States / cities: Redwood City, California

Conditions: Sarcopenia
Interventions: Outpatient Muscle Biopsy; Procedure
Lead sponsor: University of Florida; Other
Eligibility: 65 Years and older
Enrollment: 30 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2016 – 2019
U.S. locations: 1
States / cities: Gainesville, Florida

Conditions: Congenital Heart Disease
Interventions: transfusion strategy, Low Hb transfusion group; Other
Lead sponsor: University of Rochester; Other
Eligibility: 4 Months to 7 Years
Enrollment: 60 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2006 – 2009
U.S. locations: 1
States / cities: Rochester, New York

Conditions: Empty Nose Syndrome, Atrophic Rhinitis
Interventions: Botulinum Toxin Type A; Drug
Lead sponsor: Mayo Clinic; Other
Eligibility: 18 Years to 65 Years
Enrollment: 9 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2008 – 2009
U.S. locations: 1
States / cities: Rochester, Minnesota

Conditions: Contrast Media
Interventions: Gadoxetic acid disodium (Primovist, BAY86-4873); Drug
Lead sponsor: Bayer; Industry
Eligibility: 18 Years and older
Enrollment: 357 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2009 – 2013
U.S. locations: 12
States / cities: Los Angeles, California • Jacksonville, Florida • Honolulu, Hawaii + 9 more

Conditions: Degenerative Disc Disease Lumbar, Spinal Stenosis, Lumbar Spondylolisthesis
Interventions: Multimodal Analgesia, Patient controlled analgesia; Other
Lead sponsor: Rush University Medical Center; Other
Eligibility: Not listed
Enrollment: 42 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2013 – 2017
U.S. locations: 1
States / cities: Chicago, Illinois

Conditions: Total Shoulder Arthroplasty, Iodine, Shoulder Surgery
Interventions: Total shoulder arthroplasty, Iodine impregnated drapes, Tissue Culture Samples; Procedure · Drug
Lead sponsor: tnicholson; Other
Eligibility: 18 Years and older · Male only
Enrollment: 128 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2026 – 2029
U.S. locations: 1
States / cities: Philadelphia, Pennsylvania

Conditions: Acute Coronary Syndrome, Myocardial Infarction, Troponin
Interventions: Not listed
Lead sponsor: Hennepin Healthcare Research Institute; Other
Eligibility: 18 Years and older
Enrollment: 1,927 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2014 – 2021
U.S. locations: 1
States / cities: Minneapolis, Minnesota

Conditions: IBD (Inflammatory Bowel Disease), IBD, IBD - Inflammatory Bowel Disease
Interventions: Confocal Laser Endomicroscopy; Device
Lead sponsor: Cook Children's Health Care System; Other
Eligibility: 2 Years to 21 Years
Enrollment: 40 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2025 – 2028
U.S. locations: 2
States / cities: Arlington, Texas • Fort Worth, Texas

Conditions: Arthroplasties, Hip Replacement
Interventions: REDAPT Revision Femoral System modular stem; Device
Lead sponsor: Smith & Nephew, Inc.; Industry
Eligibility: Not listed
Enrollment: 140 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2016 – 2020
U.S. locations: 3
States / cities: Louisville, Kentucky • Detroit, Michigan • Portland, Oregon

Conditions: Choledocholithiasis, Cholangiocarcinoma, Benign Stricture of Common Bile Duct
Interventions: Blood culture ( aerobic and anaerobic); Other
Lead sponsor: Texas Tech University Health Sciences Center, El Paso; Other
Eligibility: 18 Years to 80 Years
Enrollment: 60 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2012 – 2013
U.S. locations: 1
States / cities: El Paso, Texas

Conditions: Pancreatobiliary Disease, Altered Gastric Anatomy
Interventions: Endoscopic Retrograde Cholangiopancreatography (ERCP); Procedure
Lead sponsor: University of Florida; Other
Eligibility: 18 Years and older
Enrollment: 7 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2007 – 2015
U.S. locations: 1
States / cities: Gainesville, Florida

Conditions: Malignant Abdominal Neoplasm, Malignant Pelvic Neoplasm, Recurrent Colon Carcinoma, Recurrent Desmoplastic Small Round Cell Tumor, Recurrent Fallopian Tube Carcinoma, Recurrent Gastric Carcinoma, Recurrent Liposarcoma, Recurrent Malignant Mesothelioma, Recurrent Ovarian Carcinoma, Recurrent Primary Peritoneal Carcinoma, Recurrent Rectal Carcinoma, Recurrent Rhabdomyosarcoma, Recurrent Sarcoma, Refractory Colon Carcinoma, Refractory Desmoplastic Small Round Cell Tumor, Refractory Fallopian Tube Carcinoma, Refractory Gastric Carcinoma, Refractory Liposarcoma, Refractory Malignant Mesothelioma, Refractory Ovarian Carcinoma, Refractory Primary Peritoneal Carcinoma, Refractory Rectal Carcinoma, Refractory Rhabdomyosarcoma, Refractory Sarcoma, Resectable Liposarcoma, Resectable Malignant Mesothelioma, Resectable Sarcoma
Interventions: Cisplatin, Cytoreductive Surgery, Doxorubicin, Hyperthermic Intraperitoneal Chemotherapy, Sodium Thiosulfate, Computed Tomography, Magnetic Resonance Imaging, Positron Emission Tomography, Biospecimen Collection; Drug · Procedure
Lead sponsor: Mayo Clinic; Other
Eligibility: 1 Year to 25 Years
Enrollment: 2 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2019 – 2024
U.S. locations: 1
States / cities: Rochester, Minnesota

Search by objective public record fields.

Investigational Extended Wear Insulin Infusion Set in People With Type 1 Diabetes

The Evicel Post-Authorization Surveillance Study

Door To Unloading With IMPELLA CP System in Acute Myocardial Infarction - Safety and Feasibility Study

Rheos System for the Treatment of HFpEF Heart Failure

International Study of Inflammation in COVID-19

A Study of miRNA 371 in Patients With Germ Cell Tumors

Conventional Home Exercise Programs Versus Electronic Home Exercise Versus Artificial Intelligence "Virtual Therapy" for Anterior Knee Pain

Incidence of Difficult Airway and Difficult Neuraxial Placement in Obstetric Patients

Efficacy and Safety of Intraosseous Antibiotic Prophylaxis in Total Hip Replacement

Utility of Liposomal Bupivacaine Transversus Abdominal Plane Block for Open Myomectomy

A Prospective Study of Clinical Outcomes Following a Single Intradiscal Injection of Bone Marrow Aspirate Concentrate (BMAC) for Single Level Discogenic Low Back Pain

SCS for the Treatment Of Chronic Pain of the Upper Extremities

A Prospective Study Of Biomarkers Of Skeletal Muscle Atrophy

Transfusion Strategies in Pediatric Cardiothoracic Surgery

Benefits of the Use of Botox in the Treatment of Empty Nose Syndrome Syndrome

Primovist / Eovist in Renally Impaired Patients

Multimodal Analgesia Versus Routine Care Pain Management

Iodine Drapes Used in TSA

Use of Abbott High Sensitivity Troponin I Assay In Acute Coronary Syndromes

Ex-vivo Confocal Imaging and Proteomic Profiling to Determine Treatment Response in Children With IBD

REDAPT Retrospective-Prospective Modular Stem Study

Prospective Study of the Risk of Bacteremia in Directed Cholangioscopic Examination of the CBD

Evaluation of Pancreatobiliary Disorders in Patients With Altered Gastric Anatomy

Heated Intra-peritoneal Chemotherapy With Doxorubicin and Cisplatin for Abdominal for Pelvic Tumors in Pediatric Patients